Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Hypertension and diabetes

Journal of Human Hypertension volume 16, pages S56–S60 (2002)Cite this article

Abstract

Diabetes and hypertension will become increasingly common as the population becomes older and more obese. Together, they markedly increase cardiovascular and renal damage, placing all diabetic hypertensives at high risk. Fortunately, the appropriate use of lifestyle changes and multiple drugs will always slow and often stop the progression of this damage.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Amri K et al. Adverse effects of hyperglycemia on kidney development in rats Diabetes 1999 48: 2240–2245

    Article  CAS  PubMed  Google Scholar 

  2. Mokdad AH et al. The spread of the obesity epidemic in the United States, 1991–1998 JAMA 1999 282: 1519–1522

    Article  CAS  PubMed  Google Scholar 

  3. Samaras K, Campbell LV . Increasing incidence of type 2 diabetes in the third millennium Diabetes Care 2000 23: 441–442

    Article  CAS  PubMed  Google Scholar 

  4. Willett WC, Dietz WH, Colditz GA . Guidelines for healthy weight N Engl J Med 1999 341: 427–434

    Article  CAS  PubMed  Google Scholar 

  5. Wei M et al. The association between cardiorespiratory fitness and impaired fasting glucose and type 2 diabetes mellitus in men Ann Intern Med 1999 130: 89–96

    Article  CAS  PubMed  Google Scholar 

  6. He J et al. Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults JAMA 1999 282: 2027–2034

    Article  CAS  PubMed  Google Scholar 

  7. Valmadrid CT et al. Alcohol intake and the risk of coronary heart disease mortality in persons with older-onset diabetes mellitus JAMA 1999 282: 239–246

    Article  CAS  PubMed  Google Scholar 

  8. Hansson L et al. Effects of intensive blood-pressure lowering and low-dose aspirin inpatients with hypertension:ϑprincipal results of the Hypertension Optimal Treatment (HOT) randomised trial Lancet 1998 351: 1755–1762

    Article  CAS  PubMed  Google Scholar 

  9. Gaede P et al. Intensified multifactorial intervention inpatients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study Lancet 1999 353: 617–622

    Article  CAS  PubMed  Google Scholar 

  10. Lievre M et al. Efficacy of diuretics and beta-blockers in diabetic hypertensivepatients Diabetes Care 2000 23: B65–B71

    PubMed  Google Scholar 

  11. UK Prospective Diabetes Study Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39 BMJ 1998 317: 713–720

  12. Giordano M et al. Effects of angiotensin-converting enzyme inhibitors, Ca2+ channel antagonists and α-adrenergic blockers on glucose and lipid metabolism in NIDDMpatients with hypertension Diabetes 1995 44: 665–671

    Article  CAS  PubMed  Google Scholar 

  13. Jollis JG et al. Calcium channel blockers and mortality in elderlypatients with myocardial infarction Arch Intern Med 1999 159: 2341–2348

    Article  CAS  PubMed  Google Scholar 

  14. Tuomilehto J et al. Effects of calcium-channel blockade in olderpatients with diabetes and systolic hypertension N Engl J Med 1999 340: 677–684

    Article  CAS  PubMed  Google Scholar 

  15. Fogari R et al. Long-term effects of ramipril and nitrendipine on albuminuria in hypertensivepatients with type II diabetes and impaired renal function J Hum Hypertens 1999 13: 47–53

    Article  CAS  PubMed  Google Scholar 

  16. Mathiesen ER et al. Randomised controlled trial of long term efficacy of captopril on preservation of kidney function in normotensivepatients with insulin dependent diabetes and microalbuminuria BMJ 1999 319: 24–25

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Hansson L et al. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial Lancet 1999 353: 611–616

    Article  CAS  PubMed  Google Scholar 

  18. Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy Lancet 2000 355: 246 253–259

  19. Pitt B et al. Randomised trial of losartan versus captopril inpatients over 65 with heart failure (Evaluation of Losartan In The Elderly Study, ELITE) Lancet 1997 349: 747–752

    Article  CAS  PubMed  Google Scholar 

  20. Pitt B et al. Effect of losartan compared with captopril on mortality inpatients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE II Lancet 2000 355: 1582–1587

    Article  CAS  PubMed  Google Scholar 

  21. Bakris GL et al. Differential effects of valsartan (V) and lisinopril (L) on potassium (K+) homeostasis in hypertensivepatients with nephropathy Am J Hypertens 1999 12: 36A

    Article  Google Scholar 

  22. Fogari R et al. Adding losartan to lisinopril therapy inpatients with hypertension: assessment by 24-hour ambulatory blood pressure monitoring Curr Ther Res 1999 60: 326

    Article  CAS  Google Scholar 

  23. Ritz E, Orth SR . Nephropathy inpatients with type 2 diabetes mellitus N Engl J Med 1999 341: 1127–1132

    Article  CAS  PubMed  Google Scholar 

  24. Bakris GL . Maximizing cardiorenal benefit in the management of hypertension: achieving blood pressure goals J Clin Hypertens 1999 1: 141–147

    Google Scholar 

  25. Kaplan NM . Management of hypertension in patients with type 2 diabetic mellitus: guidelines based on current evidence Ann Intern Med 2001 135: 1079–1083

    Article  CAS  PubMed  Google Scholar 

  26. Chan JCN et al. Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabeticpatients Kidney Int 2000 57: 590–600

    Article  CAS  PubMed  Google Scholar 

  27. Velussi M et al. Effects of cilazapril and amlodipine on kidney function in hypertensive NIDDMpatients Diabetes 1996 45: 216–222

    Article  CAS  PubMed  Google Scholar 

  28. Estacio RO et al. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes inpatients with non-insulin-dependent diabetes and hypertension N Engl J Med 1998 338: 645–652

    Article  CAS  PubMed  Google Scholar 

  29. Bakris GL, Weir MR, DeQuattro V, McMahon FG . Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy Kidney Int 1998 54: 1283–1289

    Article  CAS  PubMed  Google Scholar 

  30. Tatti P et al. Outcome results of the fosinopril versus amlodipine cardiovascular events randomized trial (FACET) inpatients with hypertension and NIDDM Diabetes Care 1998 21: 597–603

    Article  CAS  PubMed  Google Scholar 

  31. Hattori Y, Hattori S, Kasai K . Troglitazone upregulates nitric oxide synthesis in vascular smooth muscle cells Hypertension 1999 33: 943–948

    Article  CAS  PubMed  Google Scholar 

  32. Nazzaro P et al. Distinct and combined vascular effects of ACE blockade and HMG-CoA reductase inhibition in hypertensive subjects Hypertension 1999 33: 719–725

    Article  CAS  PubMed  Google Scholar 

  33. Samaras K et al. Effects of postmenopausal hormone replacement therapy on central abdominal fat, glycemic control, lipid metabolism and vascular factors in type 2 diabetes Diabetes Care 1999 22: 1401–1407

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Texas Southwestern Medical School, Dallas, TX, USA

    N M Kaplan

Authors
  1. N M Kaplan
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kaplan, N. Hypertension and diabetes. J Hum Hypertens 16 (Suppl 1), S56–S60 (2002). https://doi.org/10.1038/sj.jhh.1001344

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1001344

Keywords

This article is cited by

Search

Advanced search

Quick links